2023-11-20 |
2023-11-16 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
259
-0.3%
4,13
1 070
USD
|
259
-0.3%
|
4,13
|
1 070
USD
|
|
2023-08-08 |
2023-08-08 |
VP
Vente planifiée
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
10 550
-4.7%
6,54
68 997
USD
|
10 550
-4.7%
|
6,54
|
68 997
USD
|
|
2023-08-08 |
2023-08-07 |
V
Vente
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
5 652
-2.4%
6,78
38 321
USD
|
5 652
-2.4%
|
6,78
|
38 321
USD
|
|
2023-06-21 |
2023-06-20 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
64 961
-14.0%
8,14
528 783
USD
|
64 961
-14.0%
|
8,14
|
528 783
USD
|
|
2023-06-21 |
2023-06-20 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
70 000
-13.1%
8,14
569 800
USD
|
70 000
-13.1%
|
8,14
|
569 800
USD
|
|
2023-06-20 |
2023-06-15 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
14 328
-3.5%
8,53
122 218
USD
|
14 328
-3.5%
|
8,53
|
122 218
USD
|
|
2023-06-20 |
2023-06-15 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
55 672
-12.2%
8,53
474 882
USD
|
55 672
-12.2%
|
8,53
|
474 882
USD
|
|
2023-06-06 |
2023-06-02 |
V
Vente
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
38 000
-7.7%
7,16
272 080
USD
|
38 000
-7.7%
|
7,16
|
272 080
USD
|
|
2023-04-12 |
2023-04-11 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 308
-1.3%
8,63
19 918
USD
|
2 308
-1.3%
|
8,63
|
19 918
USD
|
|
2023-04-12 |
2023-04-10 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
817
-0.5%
8,50
6 945
USD
|
817
-0.5%
|
8,50
|
6 945
USD
|
|
2023-03-29 |
2023-03-27 |
VP
Vente planifiée
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
2 341
-10.2%
8,49
19 878
USD
|
2 341
-10.2%
|
8,49
|
19 878
USD
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
17 155
-8.8%
8,60
147 533
USD
|
17 155
-8.8%
|
8,60
|
147 533
USD
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
9 813
-4.1%
8,60
84 392
USD
|
9 813
-4.1%
|
8,60
|
84 392
USD
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
13 387
-8.7%
8,60
115 128
USD
|
13 387
-8.7%
|
8,60
|
115 128
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
229
-0.3%
8,58
1 965
USD
|
229
-0.3%
|
8,58
|
1 965
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
3 300
-3.6%
8,57
28 281
USD
|
3 300
-3.6%
|
8,57
|
28 281
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
6 816
-3.9%
8,57
58 413
USD
|
6 816
-3.9%
|
8,57
|
58 413
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
6 529
-3.2%
8,57
55 954
USD
|
6 529
-3.2%
|
8,57
|
55 954
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
6 661
-2.7%
8,57
57 085
USD
|
6 661
-2.7%
|
8,57
|
57 085
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
5 491
-3.5%
8,57
47 058
USD
|
5 491
-3.5%
|
8,57
|
47 058
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
11 749
-5.0%
8,57
100 689
USD
|
11 749
-5.0%
|
8,57
|
100 689
USD
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
RUBINSTEIN JULIE
President
Dirigeant
|
22 668
-6.3%
8,57
194 265
USD
|
22 668
-6.3%
|
8,57
|
194 265
USD
|
|
2023-01-11 |
2023-01-10 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 130
-1.8%
8,58
18 275
USD
|
2 130
-1.8%
|
8,58
|
18 275
USD
|
|
2023-01-11 |
2023-01-09 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
995
-0.9%
8,50
8 458
USD
|
995
-0.9%
|
8,50
|
8 458
USD
|
|
2022-11-01 |
2022-11-01 |
VP
Vente planifiée
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
31 066
-21.3%
8,00
248 528
USD
|
31 066
-21.3%
|
8,00
|
248 528
USD
|
|
2022-10-11 |
2022-10-10 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 284
-1.9%
7,13
16 285
USD
|
2 284
-1.9%
|
7,13
|
16 285
USD
|
|
2022-07-08 |
2022-07-08 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 300
-1.9%
10,47
24 081
USD
|
2 300
-1.9%
|
10,47
|
24 081
USD
|
|
2022-03-09 |
2022-03-09 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
14 815
-0.8%
12,46
184 595
USD
|
14 815
-0.8%
|
12,46
|
184 595
USD
|
|
2022-03-10 |
2022-03-08 |
VP
Vente planifiée
|
BALDO LANCE
Chief Medical Officer
Dirigeant
|
3 350
-16.3%
11,43
38 291
USD
|
3 350
-16.3%
|
11,43
|
38 291
USD
|
|
2022-03-10 |
2022-03-08 |
VP
Vente planifiée
|
LO FRANCIS
Chief People Officer
Dirigeant
|
3 582
-3.8%
11,44
40 978
USD
|
3 582
-3.8%
|
11,44
|
40 978
USD
|
|
2022-03-10 |
2022-03-08 |
VP
Vente planifiée
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
2 387
-3.2%
11,44
27 307
USD
|
2 387
-3.2%
|
11,44
|
27 307
USD
|
|
2022-03-09 |
2022-03-08 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
14 815
-0.8%
11,38
168 595
USD
|
14 815
-0.8%
|
11,38
|
168 595
USD
|
|
2022-03-09 |
2022-03-07 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
14 315
-0.7%
11,53
165 052
USD
|
14 315
-0.7%
|
11,53
|
165 052
USD
|
|
2022-03-09 |
2022-03-07 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
500
-0.0%
12,22
6 110
USD
|
500
-0.0%
|
12,22
|
6 110
USD
|
|
2021-12-23 |
2021-12-22 |
VP
Vente planifiée
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
15 338
-50.5%
30,00
460 140
USD
|
15 338
-50.5%
|
30,00
|
460 140
USD
|
|
2021-12-23 |
2021-12-22 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
10 000
-31.6%
30,00
300 000
USD
|
10 000
-31.6%
|
30,00
|
300 000
USD
|
|
2021-11-19 |
2021-11-18 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
300
-0.4%
31,36
9 408
USD
|
300
-0.4%
|
31,36
|
9 408
USD
|
|
2021-11-19 |
2021-11-17 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 700
-5.1%
32,05
118 585
USD
|
3 700
-5.1%
|
32,05
|
118 585
USD
|
|
2021-11-12 |
2021-11-10 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
5 000
-18.8%
33,93
169 650
USD
|
5 000
-18.8%
|
33,93
|
169 650
USD
|
|
2021-11-12 |
2021-11-09 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
5 000
-18.8%
36,03
180 150
USD
|
5 000
-18.8%
|
36,03
|
180 150
USD
|
|
2021-10-21 |
2021-10-21 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 700
-5.1%
33,73
124 801
USD
|
3 700
-5.1%
|
33,73
|
124 801
USD
|
|
2021-10-21 |
2021-10-20 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 700
-5.1%
33,71
124 727
USD
|
3 700
-5.1%
|
33,71
|
124 727
USD
|
|
2021-10-21 |
2021-10-19 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 500
-4.8%
33,76
118 160
USD
|
3 500
-4.8%
|
33,76
|
118 160
USD
|
|
2021-10-21 |
2021-10-19 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
300
-0.4%
32,91
9 873
USD
|
300
-0.4%
|
32,91
|
9 873
USD
|
|
2021-10-08 |
2021-10-08 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
1 801
-3.4%
33,67
60 640
USD
|
1 801
-3.4%
|
33,67
|
60 640
USD
|
|
2021-10-08 |
2021-10-08 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 895
-5.3%
32,96
128 379
USD
|
3 895
-5.3%
|
32,96
|
128 379
USD
|
|
2021-10-08 |
2021-10-07 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 695
-5.1%
33,68
124 448
USD
|
3 695
-5.1%
|
33,68
|
124 448
USD
|
|
2021-10-08 |
2021-10-07 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
200
-0.3%
32,50
6 500
USD
|
200
-0.3%
|
32,50
|
6 500
USD
|
|
2021-10-08 |
2021-10-06 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 895
-5.3%
32,27
125 692
USD
|
3 895
-5.3%
|
32,27
|
125 692
USD
|
|
2021-10-07 |
2021-10-06 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
5 000
-18.8%
32,30
161 500
USD
|
5 000
-18.8%
|
32,30
|
161 500
USD
|
|
2021-10-07 |
2021-10-05 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
5 000
-18.8%
32,51
162 550
USD
|
5 000
-18.8%
|
32,51
|
162 550
USD
|
|
2021-07-21 |
2021-07-21 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
2 495
-3.5%
38,11
95 084
USD
|
2 495
-3.5%
|
38,11
|
95 084
USD
|
|
2021-07-21 |
2021-07-21 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
1 400
-1.9%
37,29
52 206
USD
|
1 400
-1.9%
|
37,29
|
52 206
USD
|
|
2021-07-21 |
2021-07-20 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
2 595
-3.6%
37,82
98 143
USD
|
2 595
-3.6%
|
37,82
|
98 143
USD
|
|
2021-07-21 |
2021-07-20 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
1 300
-1.8%
36,81
47 853
USD
|
1 300
-1.8%
|
36,81
|
47 853
USD
|
|
2021-07-21 |
2021-07-19 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
2 622
-3.6%
37,33
97 879
USD
|
2 622
-3.6%
|
37,33
|
97 879
USD
|
|
2021-07-21 |
2021-07-19 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
1 273
-1.7%
36,70
46 719
USD
|
1 273
-1.7%
|
36,70
|
46 719
USD
|
|
2021-07-08 |
2021-07-07 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
3 514
-14.0%
39,20
137 749
USD
|
3 514
-14.0%
|
39,20
|
137 749
USD
|
|
2021-07-08 |
2021-07-07 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
6 486
-20.5%
38,17
247 571
USD
|
6 486
-20.5%
|
38,17
|
247 571
USD
|
|
2021-07-08 |
2021-07-06 |
VP
Vente planifiée
|
Cohen Chad M
Chief Financial Officer
Dirigeant
|
10 000
-31.6%
38,83
388 300
USD
|
10 000
-31.6%
|
38,83
|
388 300
USD
|
|
2021-06-21 |
2021-06-18 |
VP
Vente planifiée
|
Palaniappan Jyoti
SVP, Diagnostics, T-Detect
Dirigeant
|
1 301
-12.4%
39,80
51 780
USD
|
1 301
-12.4%
|
39,80
|
51 780
USD
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
4 166
-21.7%
40,00
166 640
USD
|
4 166
-21.7%
|
40,00
|
166 640
USD
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
4 000
-72.7%
40,00
160 000
USD
|
4 000
-72.7%
|
40,00
|
160 000
USD
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
Palaniappan Jyoti
SVP, Diagnostics, T-Detect
Dirigeant
|
651
-6.6%
40,00
26 040
USD
|
651
-6.6%
|
40,00
|
26 040
USD
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
14 583
-20.1%
40,00
583 320
USD
|
14 583
-20.1%
|
40,00
|
583 320
USD
|
|
2021-06-17 |
2021-06-17 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
4 255
-0.2%
39,76
169 179
USD
|
4 255
-0.2%
|
39,76
|
169 179
USD
|
|
2021-06-17 |
2021-06-17 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
1 000
-0.1%
38,55
38 550
USD
|
1 000
-0.1%
|
38,55
|
38 550
USD
|
|
2021-06-17 |
2021-06-16 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
4 745
-0.3%
38,13
180 927
USD
|
4 745
-0.3%
|
38,13
|
180 927
USD
|
|
2021-06-17 |
2021-06-15 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
900
-0.1%
39,23
35 307
USD
|
900
-0.1%
|
39,23
|
35 307
USD
|
|
2021-06-17 |
2021-06-15 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
19 100
-1.1%
38,22
730 002
USD
|
19 100
-1.1%
|
38,22
|
730 002
USD
|
|
2021-06-16 |
2021-06-14 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
8 914
-13.3%
38,77
345 596
USD
|
8 914
-13.3%
|
38,77
|
345 596
USD
|
|
2021-06-16 |
2021-06-14 |
VP
Vente planifiée
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
2 500
-62.4%
38,56
96 400
USD
|
2 500
-62.4%
|
38,56
|
96 400
USD
|
|
2021-06-11 |
2021-06-11 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
3 895
-5.3%
38,41
149 607
USD
|
3 895
-5.3%
|
38,41
|
149 607
USD
|
|
2021-06-11 |
2021-06-10 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
2 795
-3.9%
37,87
105 847
USD
|
2 795
-3.9%
|
37,87
|
105 847
USD
|
|
2021-06-11 |
2021-06-10 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
1 100
-1.5%
36,77
40 447
USD
|
1 100
-1.5%
|
36,77
|
40 447
USD
|
|